chr2-63056287-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_014562.4(OTX1):c.1036C>A(p.Gln346Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
OTX1
NM_014562.4 missense
NM_014562.4 missense
Scores
5
12
2
Clinical Significance
Conservation
PhyloP100: 7.90
Genes affected
OTX1 (HGNC:8521): (orthodenticle homeobox 1) This gene encodes a member of the bicoid sub-family of homeodomain-containing transcription factors. The encoded protein acts as a transcription factor and may play a role in brain and sensory organ development. A similar protein in mouse is required for proper brain and sensory organ development and can cause epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.885
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTX1 | NM_014562.4 | c.1036C>A | p.Gln346Lys | missense_variant | 5/5 | ENST00000282549.7 | NP_055377.1 | |
OTX1 | NM_001199770.2 | c.1036C>A | p.Gln346Lys | missense_variant | 5/5 | NP_001186699.1 | ||
OTX1 | NR_130153.2 | n.1399C>A | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTX1 | ENST00000282549.7 | c.1036C>A | p.Gln346Lys | missense_variant | 5/5 | 1 | NM_014562.4 | ENSP00000282549.2 | ||
OTX1 | ENST00000366671.7 | c.1036C>A | p.Gln346Lys | missense_variant | 5/5 | 3 | ENSP00000355631.3 | |||
OTX1 | ENST00000405984.8 | n.*845C>A | non_coding_transcript_exon_variant | 5/5 | 2 | ENSP00000385782.4 | ||||
OTX1 | ENST00000405984.8 | n.*845C>A | 3_prime_UTR_variant | 5/5 | 2 | ENSP00000385782.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2024 | The c.1036C>A (p.Q346K) alteration is located in exon 5 (coding exon 3) of the OTX1 gene. This alteration results from a C to A substitution at nucleotide position 1036, causing the glutamine (Q) at amino acid position 346 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
L;L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;P
Vest4
MutPred
Loss of catalytic residue at Q346 (P = 0.0187);Loss of catalytic residue at Q346 (P = 0.0187);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.